Skip to main content

New Menu

  • Platform
  • Pharma
  • Clinical
    • Clinical Trials
  • Publications
  • About Us
    • Team
    • Press Releases
    • Blog
    • Articles
    • Collaborators
    • Videos
    • Careers
  • Portal
Cellworks Logo Cellworks Logo

New Menu

  • Platform
  • Pharma
  • Clinical
    • Clinical Trials
  • Publications
  • About Us
    • Team
    • Press Releases
    • Blog
    • Articles
    • Collaborators
    • Videos
    • Careers
  • Portal
  • Platform
  • Pharma
  • Clinical
    • Overview
    • Clinical Trials
  • Publications
  • About Us
    • Overview
    • Team
    • Press Releases
    • Blog
    • Articles
    • Collaborators
    • Videos
    • Careers
  • Portal
  • Home page banner

    Precision Biosimulation

    Improve drug development and patient outcomes

    WATCH VIDEO

    The Future of Cancer Treatment:
    Sequence, Biosimulate, Treat.

    The Cancer Letter: Cellworks CMO Dr. Michael Castro explains how modern oncology is undergoing a transformation.
    Read Article
    Precise
PHARMA

Improve therapy success through precision drug development

Read More
Personalized treatments for your patients
PHYSICIAN

Extend lives with cancer treatment predictors

Read More
PATIENT

Personalized treatment today for a better tomorrow

Read More
Insured support for cancer treatment
PAYER

Effective intervention for better patient outcomes prolongs lives and saves costs

Read More
Drug development through software cell modeling
TECHNOLOGY

Precision by Biosimulation

BIOSIMULATION
PLATFORM

PRECISION MEDICINE PRODUCTS
FEATURED CONTENT

FEATURED ARTICLE

The new therapeutic imperative in cancer management: Sequence, biosimulate, treat.

FEATURED PUBLICATION

Cellworks Singula™ Therapy Response Index (TRI) Identifies Superior OS Outcomes for NSCLC Patients: myCare-203A

FEATURED VIDEO

View how personalized therapy biosimulation works

FEATURED BLOG

Beyond AI: The Critical Role of Biology in Personalized Cancer Therapy
VIEW ALL 
NEWS

Cellworks Study Identifies Genomic Markers of Chemotherapy Benefit and…

Patients with TP53, KRAS, and CD274 aberrations showed decreased chemotherapy benefit,…

Cellworks Study Reveals Tumor Microenvironment and TLS Dynamics Together…

Novel Model Integrating TME Composition with TLS Gene Signatures Predicts Meaningful Su…

READ ALL 
COLLABORATORS

OUR PARTNERS IN REVOLUTIONIZING CANCER TREATMENT.

 VIEW ALL 
  • Terms of Use
  • Privacy Policy
  • HIPAA Notice
  • Contact Us

© 2025 www.cellworks.life

  • Platform
  • Pharma
  • Clinical
    • Overview
    • Clinical Trials
  • Publications
  • About Us
    • Overview
    • Team
    • Press Releases
    • Blog
    • Articles
    • Collaborators
    • Videos
    • Careers
  • Portal

STAY INFORMED

Top